bayesian dose-optimizing software programs (Wolters Kluwer Health)
90
Structured Review
Wolters Kluwer Health
bayesian dose-optimizing software programs
Bayesian Dose Optimizing Software Programs, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bayesian+dose-optimizing+software/bayesian+dose+optimizing+software+programs/10__1097_slash_ftd__0000000000000910-107-6-11
Average 90 stars, based on 1 article reviews
Bayesian Dose Optimizing Software Programs, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bayesian+dose-optimizing+software/bayesian+dose+optimizing+software+programs/10__1097_slash_ftd__0000000000000910-107-6-11
Average 90 stars, based on 1 article reviews
bayesian dose-optimizing software programs - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Comparison:Article Title: Implementation of Vancomycin Therapeutic Monitoring Guidelines: Focus on Bayesian Estimation Tools in Neonatal and Pediatric Patients Article Snippet: Background: The 2020 consensus guidelines for vancomycin therapeutic monitoring recommend using Bayesian estimation targeting the ratio of the area under the curve over 24 hours to minimum inhibitory concentration as an optimal approach to individualize therapy in pediatric patients.. To support institutional guideline implementation in children, the objective of this study was to comprehensively assess and compare published population-based pharmacokinetic (PK) vancomycin models and available Bayesian estimation tools, specific to neonatal and pediatric patients. Software:Article Title: Implementation of Vancomycin Therapeutic Monitoring Guidelines: Focus on Bayesian Estimation Tools in Neonatal and Pediatric Patients Article Snippet: Background: The 2020 consensus guidelines for vancomycin therapeutic monitoring recommend using Bayesian estimation targeting the ratio of the area under the curve over 24 hours to minimum inhibitory concentration as an optimal approach to individualize therapy in pediatric patients.. To support institutional guideline implementation in children, the objective of this study was to comprehensively assess and compare published population-based pharmacokinetic (PK) vancomycin models and available Bayesian estimation tools, specific to neonatal and pediatric patients. |